These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 3039340

  • 21. Does [3H]2-methoxy-idazoxan (RX 821002) detect more alpha-2-adrenoceptor agonist high-affinity sites than [3H]rauwolscine? A comparison of nine tissues and cell lines.
    Erdbrügger W, Raulf M, Otto T, Michel MC.
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1287-94. PubMed ID: 7791100
    [Abstract] [Full Text] [Related]

  • 22. HepG2 and SK-N-MC: two human models to study alpha-2 adrenergic receptors of the alpha-2C subtype.
    Schaak S, Cayla C, Blaise R, Quinchon F, Paris H.
    J Pharmacol Exp Ther; 1997 May; 281(2):983-91. PubMed ID: 9152409
    [Abstract] [Full Text] [Related]

  • 23. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation.
    Noronha-Blob L, Lowe VC, Kinnier WJ, U'Prichard DC.
    Mol Pharmacol; 1986 Dec; 30(6):526-36. PubMed ID: 3023808
    [Abstract] [Full Text] [Related]

  • 24. Human fat cell alpha-2 adrenoceptors. II. Comparative study of partial and full agonist binding parameters using [3H]clonidine and [3H]UK-14,304.
    Galitzky J, Lafontan M, Paris H, Berlan M.
    J Pharmacol Exp Ther; 1989 May; 249(2):592-600. PubMed ID: 2566682
    [Abstract] [Full Text] [Related]

  • 25. Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
    Convents A, De Backer JP, Convents D, Vauquelin G.
    Mol Pharmacol; 1987 Jul; 32(1):65-72. PubMed ID: 2885739
    [Abstract] [Full Text] [Related]

  • 26. In vitro study of alpha 2-adrenoceptor turnover and metabolism using the adenocarcinoma cell line HT29.
    Paris H, Taouis M, Galitzky J.
    Mol Pharmacol; 1987 Nov; 32(5):646-54. PubMed ID: 2891026
    [Abstract] [Full Text] [Related]

  • 27. The effects of tetramethylpyrazine on the human platelet alpha 2 adrenergic receptor adenylate cyclase system.
    Hui KK, Yu JL, Tse E, Borst S.
    Res Commun Chem Pathol Pharmacol; 1987 Oct; 58(1):3-14. PubMed ID: 2829329
    [Abstract] [Full Text] [Related]

  • 28. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors.
    Contreras ML, Wolfe BB, Molinoff PB.
    J Pharmacol Exp Ther; 1986 Apr; 237(1):154-64. PubMed ID: 2870174
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Two distinct populations of [3H]prazosin and [3H]yohimbine binding sites in the plasma membranes of rat mesenteric artery.
    Agrawal DK, Daniel EE.
    J Pharmacol Exp Ther; 1985 Apr; 233(1):195-203. PubMed ID: 2984413
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding.
    Williams LT, Snyderman R, Lefkowitz RJ.
    J Clin Invest; 1976 Jan; 57(1):149-55. PubMed ID: 1245597
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.